Default object view. Click to create a custom template, Node ID: 143104, Object ID: 84755

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

No relation

Yes

No relation

No

09/06/2016 7:00 pm

No